Skip to content

Public FDA record

Z-1590-2016: Pentaray NAV High-Density Mapping Catheter, Catalog No. D128201, D128202, D128203, D128204, D128205, D128

Recall record Z-1590-2016 for Biosense Webster, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1590-2016
Company in FDA record
Biosense Webster, Inc.
FDA record creation date
Apr 29, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Biosense Webster is recalling the Pentaray Catheters to clarify the contraindication language in the Instructions For Use (IFU) and product labeling for this catheter relative to patients with prosthetic valves.

Source facts

Action
The firm, Biosense Webster, sent an "URGENT MEDICAL DEVICE CORRECTION" letter dated 4/14/2016 to its customers. The letter described the product, problem and actions to be taken. The letter informs customers that the recall action is NOT a product removal, and that they may continue to use PENTARAY Catheters in accordance with the updated contraindication as stated in the recall letter. Customers are instructed to read and follow the Labeling Correction Notice carefully; pass on this letter to anyone in your facility that needs to be informed; maintain a copy of this letter with the PENTARAY Catheters, and sign and return the attached ACKNOWLEDGEMENT FORM immediately by email: BWI_FA_Coordinator@its.jnj.com, fax: 909-839-8514 or mail: Biosense Webster, Inc., Attn: FCA Coordinator,15715 Arrow Highway, Irwindale, CA 91706. The updated the IFU to clarify the contraindication statement as follows: "Do not use PENTARAY Catheters in patients with prosthetic valves". For questions related to this medical device correction, please contact your BWI sales representative or call 909-839-8500.
Initiated
2016-04-14
Root cause
Use error
Terminated
2016-10-14
Distribution
Worldwide Distribution: US (Nationwide) and countries of: Canada, China, Hong Kong, Indonesia, India, Japan, Korea, Malaysia, New Zealand, Singapore, Thailand, Taiwan, United Arab Emirates, Austria, Belgium, Bulgaria, Switzerland, Czech Republic, Germany, Denmark, Algeria, Spain, Finland, France, United Kingdom, Greece, Hungary, Ireland, Israel, Iraq, Iceland, Italy, Latvia, Netherlands, Norway, Poland, Portugal, Qatar, Romania, Russia, Saudi Arabia, Sweden, Turkey, South Africa.
Recall number
Z-1590-2016
Recall status
Terminated
CDRH record ID
145208
FDA record created
2016-04-29
Recall event number
73862

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗